VERSANT VENTURES BACKS APREA AB CONTINUING GLOBAL INVESTMENT STRATEGY -- Tenth company sourced by firm’s European team in the past five years -- -- Developing first ever therapy targeting the tumor suppressing protein - Ever - Document - PDFSEARCH.IO

First Page	Meta Content
	VERSANT VENTURES BACKS APREA AB CONTINUING GLOBAL INVESTMENT STRATEGY -- Tenth company sourced by firm’s European team in the past five years -- -- Developing first ever therapy targeting the tumor suppressing protein Add to Reading List Document Date: 2016-03-09 17:09:48 Open Document File Size: 46,51 KB Share Result on Facebook

UPDATE

VERSANT VENTURES BACKS APREA AB CONTINUING GLOBAL INVESTMENT STRATEGY -- Tenth company sourced by firm’s European team in the past five years -- -- Developing first ever therapy targeting the tumor suppressing proteinAdd to Reading List